Table 1 Selected clinical information for the samples included in this study.
Sample number | Localization | Diagnosis | Pre- treatment | Lymph node/liver metastasis | Mutation | Growth pattern and Immune cells |
|---|---|---|---|---|---|---|
S1_Cec A551763 | Cecum | Adenocarcinoma, mucinous, moderately differentiated | No | Yes/yes | BRAF V600E | Mucinous, IC low |
S2_Col_R A595688 | Colon (right) | Adenocarcinoma, moderately differentiated | No | Yes/yes | No KRAS mutations | Tubular to cribriform, IC low |
S3_Col_R A416371 | Colon (right) | Adenocarcinoma, areas with moderate and poor differentiation | No | Yes/no | – | 2 tumor types: I) tubular, IC low; II) extended solid, IC high |
S4_Col_Sig A120838 | Colon (Sigma) | Adenocarcinoma, moderately differentiated | No | Yes/no | No KRAS mutations | Tubular to cribriform, IC low |
S5_Rec A121573 | Rectum | Adenocarcinoma, moderately differentiateda | No | Yes/yes | – | Tubular to cribriform, IC low |
S6_Rec A938797 | Rectum | Adenocarcinoma, moderately differentiateda | No | No/no | – | Tubular, IC medium |
S7_Rec/Sig A798015a | Sigma/Rectum | non-neoplastic tissue | na | na | – | na |
